Showing results (1-10 of 324) with videos related to
Sort By:
Pageof 33
Health Affairs Scholar|December 16, 2024
Standardizing social determinants of health data: a proposal for a comprehensive screening tool to address health equity a systematic reviewSarju Ganatra, Sumanth Khadke, Ashish Kumar, et al.Journal of the American Heart Association|March 27, 2024
Association of Environmental Injustice and Cardiovascular Diseases and Risk Factors in the United StatesSumanth Khadke, Ashish Kumar, Sadeer Al-Kindi, et al.Current Atherosclerosis Reports|July 8, 2024
Social Phenotyping for Cardiovascular Risk Stratification in Electronic Health RegistriesRamzi Ibrahim, Hoang Nhat Pham, Sarju Ganatra, et al.Lancet Regional Health. Americas|August 14, 2025
Environmental justice index and prevalence of asthma and COPD in US neighborhoods- a population-based studySumanth Khadke, Vidhatri Khadke, Ashish Kumar, et al.JACC. Advances|May 30, 2025
An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor AgonistsSourbha S Dani, Bhargav Makwana, Sumanth Khadke, et al.Journal of the American Heart Association|June 18, 2025
Marine Microplastic Levels and the Prevalence of Cardiometabolic Diseases in US Coastline CountiesBhargav Makwana, Sumanth Khadke, Ashish Kumar, et al.Anaesthesia|January 8, 2025
Cardiotoxicity and peri-operative considerations in immune checkpoint inhibitor and chimeric antigen receptor T-cell therapy: a narrative reviewAishwarya Malode, Bhargav Makwana, Vahin Patel, et al.Research Square|August 7, 2024
Associations of SGLT-2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone TherapyEfstratios Koutroumpakis, Rushin Patel, Sumanth Khadke, et al.Cardiovascular Drugs and Therapy|November 11, 2024
Associations of SGLT2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone TherapyEfstratios Koutroumpakis, Rushin Patel, Sumanth Khadke, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2023
Oral Nirmatrelvir and Ritonavir for Coronavirus Disease 2019 in Vaccinated, Nonhospitalized Adults Aged 18-50 YearsJeremy Samuel Faust, Ashish Kumar, Jui Shah, et al.Pageof 33